News

Please see important message from ILAC with regards to the proposed revision of the ISO 15189:2012 Medical Laboratories – Requirements for Quality and Competence

Dear ILAC Members,

 

As many of you will be aware ILAC maintains A Liaison status with ISO/TC 212 WG 1, which is the working group responsible for the standard ISO 15189:2012 Medical Laboratories - Requirements for Quality and Competence. ISO 15189:2012 is due for Systematic Review in October 2017 and ISO/TC 212 WG 1 is conducting a survey amongst users of the standard to seek information that will be used, in conjunction with the results of the Systematic Review, to determine the extent of any revisions that may be considered necessary.

 

ILAC members who use this standard are invited to complete survey that can be accessed via the following link:

 

https://www.surveymonkey.com/r/2017_ISO15189

 

ILAC Stakeholder members are further invited to distribute this survey invitation to their members where relevant.

 

ISO/TC WG 1 has provided the following infomration on the survey:

 

Later this year ISO 15189:2012 is due for Systematic Review. At meetings of WG1 we have discussed the changes proposed to ISO/IEC 17025, the normative reference for ISO 15189, as well as changes in ISO 9001:2015. Prior to the ballot taking place for the review, we would like to obtain information from users of ISO 15189:2012.

 

A survey has been developed and we ask that you share this link with as many people as possible and encourage them to do the same. We need to hear from users in laboratories, accreditation bodies/agencies, accreditation assessors and any others who may have reason to use the standard, whether it is voluntary or mandatory use. This feedback will be shared with members of ISO/TC 212 WG1 and used together with the results of the upcoming systematic review, to determine the extent of revisions that need to be made to the standard.

 

Thank you, Sheila Woodcock, Convenor ISO/TC 212 WG1.

Cellular Blood Component Quality Monitoring EQA

If you are a participant in our Low Level Leucocyte programme, you may also be interested in the complementary Blood Component Monitoring EQA scheme, assessing red cell (RBC) and platelet (PLT) parameters, run by UK NEQAS Haematology.

 

For more information, please see below.

Cellular Blood Component Quality Monitoring EQA Flyer
Cellular_Blood_Component_Quality_Monitor[...]
Adobe Acrobat document [247.2 KB]

UK NEQAS: Coordinating Point of Care Testing Event

UK Neqas is pleased to announce a one-day meeting 'UK Neqas Coordinating Point of Care testing' at the prestigious Queen Elizabeth II Centre in Westminster, London on Friday 20th October 2017, with exhibitions from companies representing the POCT diagnostics industry.

 

A registration form and programme will be shortly available to view and download from the UK NEQAS website (www.ukneqas.org.uk); if you would like to register your interest please email office@ukneqas.org.uk and we will send the programme and registration form directly to you when available.

UK Neqas Point of Care Event Flyer
UK NEQAS POC Event.pdf
Adobe Acrobat document [184.9 KB]
UK NEQAS Point of Care Event Programme and Registration Form
ProgrammeRegistration_Form.pdf
Adobe Acrobat document [753.0 KB]

Changes to z score Limits

As a result of an internal review, we have taken the decision to adjust the performance monitoring limits for quantitative programmes.


These will be rolled out on an ongoing basis until all such quantitative programmes are amended.


Listed below are the current quantitative programmes where the changes have been made.  This will be updated as and when changes to any programmes are made and show the trial and date when the changes came into effect.

 

Programme Trial Effective From
BCR-ABL1 Major Quantification        161702 13/09/2016
Post SCT Chimerism Monitoring        161703 26/10/2016
Low Level Leucocyte Enumeration        161708 16/01/2017
CD34+ Stem Cell Enumeration        161705 23/01/2017

Immune Monitoring Alternative Technologies

161705 24/01/2017
Minimal Residual Disease for Acute Lymphoblastic Leukaemia        161704 24/01/2017
Immune Monitoring        161705 30/01/2017
Pilot Minimal Residual Disease in AML       161703 07/02/2017
Pilot Minimal Residual Disease in CLL        161703 13/02/2017
Leukaemia Immunophenotyping (Part 1)        161705 21/02/2017

 

The changes to the performance limits detailed below will be applicable to all quantitative programmes appearing in the above list unless otherwise specified.


• A result between 2.5 and -2.5 will now be classed as satisfactory


• A result between >2.5 and 3.5 or <-2.5 and -3.5 will be classed as an 'Action’ result. An ‘Action’ category highlights a potential issue to the laboratory and indicates that the laboratory should review. Two ‘Action’ results in a period of 3 samples would result in classification as a ‘Critical’


• A result above 3.5 or below -3.5 is considered to be a ‘critical’ result requiring immediate investigation by the laboratory


Please note that if you are a UK-based laboratory the relevant National Quality Assurance Advisory Panel will be automatically notified when a Critical level of performance is assigned. Non-UK laboratories are not notified to UK NQAAP’s.

Re-Registration 2017/18

Our Re-Registration window is now open for 2017/18. Please click here and log in to your account to re-register.

 

For more information, please email admin@ukneqasli.co.uk.

New Programmes for 2017/2018

Please find below the flyer for our New Programmes for 2017/2018.

 

If you would like any more information, or would like to register for any of our programmes, please contact admin@ukneqasli.co.uk.

 

Thank you.

New Programmes for 2017/2018
New Programmes 2017-2018.pdf
Adobe Acrobat document [512.6 KB]

Programmes List for 2017/2018

Please find below the flyer for all of our available programmes for 2017/2018.

 

If you would like any more information, or would like to register for any of our programmes, please contact admin@ukneqasli.co.uk.

 

Thank you.

UK NEQAS LI Services Available 2017/2018
UK NEQAS LI Services Available 2017-18 L[...]
Adobe Acrobat document [543.0 KB]

Connect with us

UK NEQAS for Leucocyte Immunophenotyping (UK NEQAS LI) now has a Facebook page and a Twitter account. We will be posting important messages to these accounts relating to our schemes so please like or follow us, respectively.

 

We hope that these feeds will act as a useful eductational resource for participants and collaborators alike, collating interesting papers, conference info, videos and news stories in haemato-oncology. As we develop our online presence we hope to publish some of our own educational content. If you have any feedback or ideas as to content you would like us to include, please do not hesitate to get in touch.

Print Print | Sitemap

Follow Us Online!
Facebook Twitter LinkedIn Youtube

Disclaimer

Last updated 27th September 2017 © UK NEQAS for Leucocyte Immunophenotyping not to be reproduced in all or part without permission.

This website uses cookies. For more information, please click here.


The UK NEQAS Organisation is a Company Limited by Guarantee (No.3012351) and a Registered UK Charity (No.1044013).